David R. Ebsworth is Director at Verona Pharma plc (VRNA). They have made 5 open-market trades across 1 company since 2021, most recently 2025-10-07.
CIK 0001207107
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $787K since 2023, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRNA | 72,000 | $7.7M |
Shares reported on the most recent Form 4, priced at the 2025-10-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRNA | SELL | 2025-08-01 | 2025-08-05 | $13.14 | $25K | +0.0% | +0.9% | N/A |
| VRNA | BUY | 2024-11-18 | 2024-11-18 | $4.44 | $178K | +11.7% | +12.9% | +81.0% |
| VRNA | BUY | 2024-11-06 | 2024-11-07 | $4.80 | $189K | -1.1% | +4.4% | +59.4% |
| VRNA | BUY | 2024-08-12 | 2024-08-14 | $2.87 | $103K | -3.7% | +7.5% | +40.7% |
| VRNA | BUY | 2023-11-06 | 2023-11-08 | $1.98 | $317K | +1.0% | +0.2% | +17.8% |
| VRNA | SELL · 10b5-1 | 2021-05-04 | 2021-05-05 | $0.84 | $9K | -9.4% | -4.8% | -3.0% |
| VRNA | SELL · 10b5-1 | 2021-02-01 | 2021-02-03 | $0.99 | $12K | +3.5% | +4.9% | -19.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.